2 news items
TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
TCRX
13 May 24
equivalents; and the Company's goals and strategy, focus, and anticipated financial performance. TScan intends such forward-looking statements
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
TCRX
16 Apr 24
of any of the Company's proprietary platforms, multiplexing, or current or future product candidates in treating patients; and the Company's goals
- Prev
- 1
- Next